Mometasone furoate Prescribing at MAPLE ACCESS PARTNERSHIP LLP

Drugs acting on the nose | Ear, Nose and Oropharynx

Items (12m)
123
Total Quantity
123
NHS Cost
£973
vs National Avg
-69.4%

MAPLE ACCESS PARTNERSHIP LLP prescribed 123 items of Mometasone furoate over the last 12 months at a cost of £973 to the NHS. This is 69.4% below the national average prescribing rate. Mometasone furoate is classified under Drugs acting on the nose in the BNF.

Monthly Prescribing Trend

Jun 2026
13
Jun 2026
12
Jun 2026
14
Jun 2026
12
Jun 2026
10
Jun 2026
9
Jun 2026
10
Jun 2026
3
Jun 2026
14
Jun 2026
9
Jun 2026
8
Jun 2026
9

Prescribing Details

Total Items123
Total Quantity123
Total NHS Cost£973
Presentations1 different forms
vs National Average-69.4%

Mometasone furoate Prescribing Comparison

This practice123 items
National average per practice402 items
Difference-69.4% vs national average
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.